Giselle C. Meléndez

Author

Giselle C. Meléndez

Also Known As

G C Melendez, G. C. Melendez, Giselle C Melendez, Giselle C Meléndez, Giselle C. Melendez, Giselle C. Meléndez, Giselle C. Meléndez, Giselle Melendez, Giselle Meléndez

Publications

Citations

H-Index

Concepts

All Affiliations

Wake Forest University University of South Carolina Medical College of Wisconsin Virginia Commonwealth University National Institutes of Health

About

Giselle C. Meléndez is an author at Wake Forest University specializing in medicine, heart failure, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	359
2	Cell Biology	3	3	86
3	Health Sciences	1	1	11
4	Public Health	1	1	41
5	Cardiothoracic Surgery	1	1	26

Giselle C. Meléndez

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in Rats Giselle C. Meléndez, Jennifer L. McLarty, Scott P. Levick, Hypertension	2010	428
Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors Jennifer H. Jordan, Sujethra Vasu, Timothy M. Morgan, Circulation Cardiovascular Imaging	2016	177
Left Ventricular Mass Change After Anthracycline Chemotherapy Jennifer H. Jordan, Sharon M. Castellino, Giselle C. Meléndez, Circulation Heart Failure	2018	132
Tryptase/Protease-Activated Receptor 2 Interactions Induce Selective Mitogen-Activated Protein Kinase Signaling and Collagen Synthesis by Cardiac Fibroblasts Jennifer L. McLarty, Giselle C. Meléndez, Gregory L. Brower, Hypertension	2011	99
TNF-α inhibition attenuates adverse myocardial remodeling in a rat model of volume overload Lynetta J. Jobe, Giselle C. Meléndez, Scott P. Levick, American Journal of Physiology-Heart and Circulatory Physiology Etanercept AdministrationHeart FailureImmunologyCardiovascular PharmacologyPathology	2009	80
Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy Marie‐Pierre Jolly, Jennifer H. Jordan, Giselle C. Meléndez, Journal of Cardiovascular Magnetic Resonance	2016	77
Doxorubicin-Induced Myocardial Fibrosis Involves the Neurokinin-1 Receptor and Direct Effects on Cardiac Fibroblasts Scott P. Levick, David R. Soto‐Pantoja, Jianli Bi, Heart Lung and Circulation InflammationCardiac MuscleDoxorubicin-induced Myocardial FibrosisFibrosisHeart Failure	2018	75
Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells Giselle C. Meléndez, Jianping Li, Brittany A. Law, Cardiovascular Research	2011	67
Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy Yismeilin R. Feliz‐Mosquea, Ashley Christensen, Adam S. Wilson, Breast Cancer Research and Treatment Cell AutophagyBreast OncologyMedicineImmunologyAutophagy	2018	54
Frequency of Left Ventricular End-Diastolic Volume–Mediated Declines in Ejection Fraction in Patients Receiving Potentially Cardiotoxic Cancer Treatment Giselle C. Meléndez, Bunyapon Sukpraphrute, Ralph B. D’Agostino, The American Journal of Cardiology Heart FailureCardiovascular DiseaseCardiac MechanicMedicineDiastolic Function	2017	41

Page 1